Skip to Content

VIP101 (Vilamit MB hyoscyamine sulfate 0.12 mg / methenamine 118 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate

Pill with imprint VIP101 is Purple, Capsule-shape and has been identified as Vilamit MB hyoscyamine sulfate 0.12 mg / methenamine 118 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg. It is supplied by Vilvet Pharmaceuticals, Inc..

Vilamit MB is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Vilamit MB hyoscyamine sulfate 0.12 mg / methenamine 118 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for VIP101

Vilamit mb hyoscyamine sulfate 0.12 mg / methenamine 118 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg VIP101

Vilamit MB

Generic Name
hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Imprint
VIP101
Strength
hyoscyamine sulfate 0.12 mg / methenamine 118 mg / methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate monobasic 40.8 mg
Color
Purple
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Vilvet Pharmaceuticals, Inc.
National Drug Code (NDC)
71186-0002
Inactive Ingredients
titanium dioxide, FD&C Yellow No. 5, FD&C Red No. 3, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

More about Vilamit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)

Consumer resources

Other brands: Uribel, Uretron DS, Uro-MP, Urin D/S, ... +16 more

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.